SK pharmteco

SK pharmteco Contract Manufacturing & Development (CDMO) Profile

CDMO

CDMO Services:
Small Molecule; Cell & Gene Therapy Drug Substance Manufacturing (API); Analytical Development Solids Analytical Development; Cell Line Development; ICH Stability Testing; Process Development; Protein Synthesis Live Viral Vaccines; Viral Vector Vaccines; Plasmid DNA; Live Biotherapeutic Products

Year Founded: 2019

Head Office: Rancho Cordova, US

Number of Facilities: 6-10

Facility locations: Europe; North America; East Asia

Website: Visit the SK pharmteco website

Linkedin: Connect on Linkedin

Current Capacity: Cell and Gene Therapy

Production: 90 viral vector batches/year (US) & 72 viral vector batches/year (FR)

2 R&D centers

Analytical development & GMP testing laboratories

Corbeil-Essonnes, France

Viral Vector Production (10,000m2),

4 x 50L, 9 x 200L, 5 x 1,000L bioreactor capacity, Analytical testing services

Pennsylvania, USA

Viral Vector Production (5,000m2),

50-500L bioreactor capacity,

Cell therapy processing, Plasmids,

Analytical testing services

Small Molecule

Production: 28 commercial lines, 10 semi-works lines, 17 pilot & kg-labs

4 R&D centers

Analytical development & GMP testing laboratories

California, USA (HQ)

GMP Production (310m3), R&D Center,

Energetic Chemistry, Chromatography COE,

Continuous Processing COE,

Analytical testing services

Virginia, USA

GMP Production (188m3),

Analytical testing services

Texas, USA

GMP Production (91m3), Hazardous Chemistries (High Pressure, Phosgene, Azides)

Swords (Dublin), Ireland

GMP Production (121m3), R&D Center,

HPAPI (ADC) & Particle Engineering COE,

Analytical testing services

Sejong, Korea

GMP Production (393m3),

Continuous Processing COE